Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1969 3
1970 2
1971 2
1972 1
1982 1
1991 1
1992 1
1994 1
1996 1
1997 2
1998 2
1999 3
2000 2
2004 1
2005 1
2007 1
2008 4
2009 1
2010 1
2011 1
2012 2
2013 4
2014 2
2015 2
2016 2
2017 1
2018 3
2019 4
2020 3
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis.
Dafni U, Michielin O, Lluesma SM, Tsourti Z, Polydoropoulou V, Karlis D, Besser MJ, Haanen J, Svane IM, Ohashi PS, Kammula US, Orcurto A, Zimmermann S, Trueb L, Klebanoff CA, Lotze MT, Kandalaft LE, Coukos G. Dafni U, et al. Among authors: trueb l. Ann Oncol. 2019 Dec 1;30(12):1902-1913. doi: 10.1093/annonc/mdz398. Ann Oncol. 2019. PMID: 31566658 Free article.
[Mushroom poisoning].
Trueb L, Carron PN, Saviuc P. Trueb L, et al. Rev Med Suisse. 2013 Aug 14;9(394):1465-70, 1472. Rev Med Suisse. 2013. PMID: 24024391 French.
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Barras D, Ghisoni E, Chiffelle J, Orcurto A, Dagher J, Fahr N, Benedetti F, Crespo I, Grimm AJ, Morotti M, Zimmermann S, Duran R, Imbimbo M, de Olza MO, Navarro B, Homicsko K, Bobisse S, Labes D, Tsourti Z, Andriakopoulou C, Herrera F, Pétremand R, Dummer R, Berthod G, Kraemer AI, Huber F, Thevenet J, Bassani-Sternberg M, Schaefer N, Prior JO, Matter M, Aedo V, Dromain C, Corria-Osorio J, Tissot S, Kandalaft LE, Gottardo R, Pittet M, Sempoux C, Michielin O, Dafni U, Trueb L, Harari A, Laniti DD, Coukos G. Barras D, et al. Among authors: trueb l. Sci Immunol. 2024 Feb 2;9(92):eadg7995. doi: 10.1126/sciimmunol.adg7995. Epub 2024 Feb 2. Sci Immunol. 2024. PMID: 38306416
[CAR-T therapy for autoimmune diseases].
Alcaraz-Serna A, Porret R, Trueb L, Ribi C, Seebach J, Muller YD. Alcaraz-Serna A, et al. Among authors: trueb l. Rev Med Suisse. 2024 Apr 3;20(868):688-693. doi: 10.53738/REVMED.2024.20.868.688. Rev Med Suisse. 2024. PMID: 38568061 Review. French.
Safety and Tolerability of Adoptive Cell Therapy in Cancer.
Wolf B, Zimmermann S, Arber C, Irving M, Trueb L, Coukos G. Wolf B, et al. Among authors: trueb l. Drug Saf. 2019 Feb;42(2):315-334. doi: 10.1007/s40264-018-0779-3. Drug Saf. 2019. PMID: 30649750 Review.
Patient-reported outcomes in adoptive cell-therapy trials: mind the gap.
Ghisoni E, Morotti M, Colomer-Lahiguera S, Eicher M, Coukos G, Trueb L, Di Maio M. Ghisoni E, et al. Among authors: trueb l. J Immunother Cancer. 2022 Dec;10(12):e006082. doi: 10.1136/jitc-2022-006082. J Immunother Cancer. 2022. PMID: 36600604 Free PMC article.
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes.
Orcurto A, Hottinger A, Wolf B, Navarro Rodrigo B, Ochoa de Olza M, Auger A, Kuntzer T, Comte D, Zimmer V, Gannon P, Kandalaft L, Michielin O, Zimmermann S, Harari A, Trueb L, Coukos G. Orcurto A, et al. Among authors: trueb l. J Immunother Cancer. 2020 Aug;8(2):e001155. doi: 10.1136/jitc-2020-001155. J Immunother Cancer. 2020. PMID: 32847987 Free PMC article.
[Role and issues of emergency medicine].
Trueb L, Yersin B. Trueb L, et al. Rev Med Suisse. 2008 Aug 20;4(167):1739. Rev Med Suisse. 2008. PMID: 18800750 French. No abstract available.
58 results